Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: Oblomov who wrote (16239)	9/6/2000 12:20:33 PM
From: patron_anejo_por_favor	Respond to of 436258

<<Agave shortage makes tequila prices rocket>> OH THE HUMANITY!!!!!! At least the strategic tequila reserve is almost filled, thanks to the recent run up in the oils.... I like WPI because they have a broader range of generics than anyone, IMO. They will not get blindsided by production quality issues. Balance sheet is great, PE 17, etc. SEPR is more of a "drug development" company than a true generic company, and Barr is a bit expensive here due to the generic Prozac hype (which will not produce any meaningful revenue for them untill the last Q of 2001, at the earliest. So WPI is a good bargain and more of a pure play here....